Report Detail

Medical Devices & Consumables COVID-19 Impact on Global Infectious Disease Testing Using PCR for IVD Market Insights, Forecast to 2026

  • RnM4018704
  • |
  • 09 June, 2020
  • |
  • Global
  • |
  • 150 Pages
  • |
  • QYResearch
  • |
  • Medical Devices & Consumables

Infectious Disease Testing Using PCR for IVD market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Infectious Disease Testing Using PCR for IVD market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Infectious Disease Testing Using PCR for IVD market is segmented into
Direct Detection
Indirect Detection

Segment by Application, the Infectious Disease Testing Using PCR for IVD market is segmented into
Hospitals
Laboratory
Other

Regional and Country-level Analysis
The Infectious Disease Testing Using PCR for IVD market is analysed and market size information is provided by regions (countries).
The key regions covered in the Infectious Disease Testing Using PCR for IVD market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and Infectious Disease Testing Using PCR for IVD Market Share Analysis

Infectious Disease Testing Using PCR for IVD market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of Infectious Disease Testing Using PCR for IVD by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in Infectious Disease Testing Using PCR for IVD business, the date to enter into the Infectious Disease Testing Using PCR for IVD market, Infectious Disease Testing Using PCR for IVD product introduction, recent developments, etc.
The major vendors covered:
Thermo Fisher
BD
Roche Diagnostics
Merck
Siemens Healthineers
Hologic
Abbott Laboratories
BioMerieux
Cepheid
Bayer
Sysmex
Ortho Clinical Diagnostics
Qiagen
Codexis
Bio-Rad Laboratories


1 Study Coverage

  • 1.1 Infectious Disease Testing Using PCR for IVD Product Introduction
  • 1.2 Key Market Segments in This Study
  • 1.3 Key Manufacturers Covered: Ranking of Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue in 2019
  • 1.4 Market by Type
    • 1.4.1 Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Type
    • 1.4.2 Direct Detection
    • 1.4.3 Indirect Detection
  • 1.5 Market by Application
    • 1.5.1 Global Infectious Disease Testing Using PCR for IVD Market Size Growth Rate by Application
    • 1.5.2 Hospitals
    • 1.5.3 Laboratory
    • 1.5.4 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Infectious Disease Testing Using PCR for IVD Industry Impact
    • 1.6.1 How the Covid-19 is Affecting the Infectious Disease Testing Using PCR for IVD Industry
      • 1.6.1.1 Infectious Disease Testing Using PCR for IVD Business Impact Assessment - Covid-19
      • 1.6.1.2 Supply Chain Challenges
      • 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
    • 1.6.2 Market Trends and Infectious Disease Testing Using PCR for IVD Potential Opportunities in the COVID-19 Landscape
    • 1.6.3 Measures / Proposal against Covid-19
      • 1.6.3.1 Government Measures to Combat Covid-19 Impact
      • 1.6.3.2 Proposal for Infectious Disease Testing Using PCR for IVD Players to Combat Covid-19 Impact
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Executive Summary

  • 2.1 Global Infectious Disease Testing Using PCR for IVD Market Size Estimates and Forecasts
    • 2.1.1 Global Infectious Disease Testing Using PCR for IVD Revenue Estimates and Forecasts 2015-2026
    • 2.1.2 Global Infectious Disease Testing Using PCR for IVD Production Capacity Estimates and Forecasts 2015-2026
    • 2.1.3 Global Infectious Disease Testing Using PCR for IVD Production Estimates and Forecasts 2015-2026
  • 2.2 Global Infectious Disease Testing Using PCR for IVD Market Size by Producing Regions: 2015 VS 2020 VS 2026
  • 2.3 Analysis of Competitive Landscape
    • 2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 2.3.2 Global Infectious Disease Testing Using PCR for IVD Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    • 2.3.3 Global Infectious Disease Testing Using PCR for IVD Manufacturers Geographical Distribution
  • 2.4 Key Trends for Infectious Disease Testing Using PCR for IVD Markets & Products
  • 2.5 Primary Interviews with Key Infectious Disease Testing Using PCR for IVD Players (Opinion Leaders)

3 Market Size by Manufacturers

  • 3.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production Capacity
    • 3.1.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production Capacity (2015-2020)
    • 3.1.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Production (2015-2020)
    • 3.1.3 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers Market Share by Production
  • 3.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue
    • 3.2.1 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers by Revenue (2015-2020)
    • 3.2.2 Global Top Infectious Disease Testing Using PCR for IVD Manufacturers Market Share by Revenue (2015-2020)
    • 3.2.3 Global Top 10 and Top 5 Companies by Infectious Disease Testing Using PCR for IVD Revenue in 2019
  • 3.3 Global Infectious Disease Testing Using PCR for IVD Price by Manufacturers
  • 3.4 Mergers & Acquisitions, Expansion Plans

4 Infectious Disease Testing Using PCR for IVD Production by Regions

  • 4.1 Global Infectious Disease Testing Using PCR for IVD Historic Market Facts & Figures by Regions
    • 4.1.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Production (2015-2020)
    • 4.1.2 Global Top Infectious Disease Testing Using PCR for IVD Regions by Revenue (2015-2020)
  • 4.2 North America
    • 4.2.1 North America Infectious Disease Testing Using PCR for IVD Production (2015-2020)
    • 4.2.2 North America Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
    • 4.2.3 Key Players in North America
    • 4.2.4 North America Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
  • 4.3 Europe
    • 4.3.1 Europe Infectious Disease Testing Using PCR for IVD Production (2015-2020)
    • 4.3.2 Europe Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
    • 4.3.3 Key Players in Europe
    • 4.3.4 Europe Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
  • 4.4 China
    • 4.4.1 China Infectious Disease Testing Using PCR for IVD Production (2015-2020)
    • 4.4.2 China Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
    • 4.4.3 Key Players in China
    • 4.4.4 China Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)
  • 4.5 Japan
    • 4.5.1 Japan Infectious Disease Testing Using PCR for IVD Production (2015-2020)
    • 4.5.2 Japan Infectious Disease Testing Using PCR for IVD Revenue (2015-2020)
    • 4.5.3 Key Players in Japan
    • 4.5.4 Japan Infectious Disease Testing Using PCR for IVD Import & Export (2015-2020)

5 Infectious Disease Testing Using PCR for IVD Consumption by Region

  • 5.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Consumption
    • 5.1.1 Global Top Infectious Disease Testing Using PCR for IVD Regions by Consumption (2015-2020)
    • 5.1.2 Global Top Infectious Disease Testing Using PCR for IVD Regions Market Share by Consumption (2015-2020)
  • 5.2 North America
    • 5.2.1 North America Infectious Disease Testing Using PCR for IVD Consumption by Application
    • 5.2.2 North America Infectious Disease Testing Using PCR for IVD Consumption by Countries
    • 5.2.3 U.S.
    • 5.2.4 Canada
  • 5.3 Europe
    • 5.3.1 Europe Infectious Disease Testing Using PCR for IVD Consumption by Application
    • 5.3.2 Europe Infectious Disease Testing Using PCR for IVD Consumption by Countries
    • 5.3.3 Germany
    • 5.3.4 France
    • 5.3.5 U.K.
    • 5.3.6 Italy
    • 5.3.7 Russia
  • 5.4 Asia Pacific
    • 5.4.1 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Application
    • 5.4.2 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption by Regions
    • 5.4.3 China
    • 5.4.4 Japan
    • 5.4.5 South Korea
    • 5.4.6 India
    • 5.4.7 Australia
    • 5.4.8 Taiwan
    • 5.4.9 Indonesia
    • 5.4.10 Thailand
    • 5.4.11 Malaysia
    • 5.4.12 Philippines
    • 5.4.13 Vietnam
  • 5.5 Central & South America
    • 5.5.1 Central & South America Infectious Disease Testing Using PCR for IVD Consumption by Application
    • 5.5.2 Central & South America Infectious Disease Testing Using PCR for IVD Consumption by Country
    • 5.5.3 Mexico
    • 5.5.3 Brazil
    • 5.5.3 Argentina
  • 5.6 Middle East and Africa
    • 5.6.1 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Application
    • 5.6.2 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption by Countries
    • 5.6.3 Turkey
    • 5.6.4 Saudi Arabia
    • 5.6.5 U.A.E

6 Market Size by Type (2015-2026)

  • 6.1 Global Infectious Disease Testing Using PCR for IVD Market Size by Type (2015-2020)
    • 6.1.1 Global Infectious Disease Testing Using PCR for IVD Production by Type (2015-2020)
    • 6.1.2 Global Infectious Disease Testing Using PCR for IVD Revenue by Type (2015-2020)
    • 6.1.3 Infectious Disease Testing Using PCR for IVD Price by Type (2015-2020)
  • 6.2 Global Infectious Disease Testing Using PCR for IVD Market Forecast by Type (2021-2026)
    • 6.2.1 Global Infectious Disease Testing Using PCR for IVD Production Forecast by Type (2021-2026)
    • 6.2.2 Global Infectious Disease Testing Using PCR for IVD Revenue Forecast by Type (2021-2026)
    • 6.2.3 Global Infectious Disease Testing Using PCR for IVD Price Forecast by Type (2021-2026)
  • 6.3 Global Infectious Disease Testing Using PCR for IVD Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

7 Market Size by Application (2015-2026)

  • 7.2.1 Global Infectious Disease Testing Using PCR for IVD Consumption Historic Breakdown by Application (2015-2020)
  • 7.2.2 Global Infectious Disease Testing Using PCR for IVD Consumption Forecast by Application (2021-2026)

8 Corporate Profiles

  • 8.1 Thermo Fisher
    • 8.1.1 Thermo Fisher Corporation Information
    • 8.1.2 Thermo Fisher Overview and Its Total Revenue
    • 8.1.3 Thermo Fisher Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.1.4 Thermo Fisher Product Description
    • 8.1.5 Thermo Fisher Recent Development
  • 8.2 BD
    • 8.2.1 BD Corporation Information
    • 8.2.2 BD Overview and Its Total Revenue
    • 8.2.3 BD Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.2.4 BD Product Description
    • 8.2.5 BD Recent Development
  • 8.3 Roche Diagnostics
    • 8.3.1 Roche Diagnostics Corporation Information
    • 8.3.2 Roche Diagnostics Overview and Its Total Revenue
    • 8.3.3 Roche Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.3.4 Roche Diagnostics Product Description
    • 8.3.5 Roche Diagnostics Recent Development
  • 8.4 Merck
    • 8.4.1 Merck Corporation Information
    • 8.4.2 Merck Overview and Its Total Revenue
    • 8.4.3 Merck Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.4.4 Merck Product Description
    • 8.4.5 Merck Recent Development
  • 8.5 Siemens Healthineers
    • 8.5.1 Siemens Healthineers Corporation Information
    • 8.5.2 Siemens Healthineers Overview and Its Total Revenue
    • 8.5.3 Siemens Healthineers Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.5.4 Siemens Healthineers Product Description
    • 8.5.5 Siemens Healthineers Recent Development
  • 8.6 Hologic
    • 8.6.1 Hologic Corporation Information
    • 8.6.2 Hologic Overview and Its Total Revenue
    • 8.6.3 Hologic Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.6.4 Hologic Product Description
    • 8.6.5 Hologic Recent Development
  • 8.7 Abbott Laboratories
    • 8.7.1 Abbott Laboratories Corporation Information
    • 8.7.2 Abbott Laboratories Overview and Its Total Revenue
    • 8.7.3 Abbott Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.7.4 Abbott Laboratories Product Description
    • 8.7.5 Abbott Laboratories Recent Development
  • 8.8 BioMerieux
    • 8.8.1 BioMerieux Corporation Information
    • 8.8.2 BioMerieux Overview and Its Total Revenue
    • 8.8.3 BioMerieux Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.8.4 BioMerieux Product Description
    • 8.8.5 BioMerieux Recent Development
  • 8.9 Cepheid
    • 8.9.1 Cepheid Corporation Information
    • 8.9.2 Cepheid Overview and Its Total Revenue
    • 8.9.3 Cepheid Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.9.4 Cepheid Product Description
    • 8.9.5 Cepheid Recent Development
  • 8.10 Bayer
    • 8.10.1 Bayer Corporation Information
    • 8.10.2 Bayer Overview and Its Total Revenue
    • 8.10.3 Bayer Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.10.4 Bayer Product Description
    • 8.10.5 Bayer Recent Development
  • 8.11 Sysmex
    • 8.11.1 Sysmex Corporation Information
    • 8.11.2 Sysmex Overview and Its Total Revenue
    • 8.11.3 Sysmex Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.11.4 Sysmex Product Description
    • 8.11.5 Sysmex Recent Development
  • 8.12 Ortho Clinical Diagnostics
    • 8.12.1 Ortho Clinical Diagnostics Corporation Information
    • 8.12.2 Ortho Clinical Diagnostics Overview and Its Total Revenue
    • 8.12.3 Ortho Clinical Diagnostics Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.12.4 Ortho Clinical Diagnostics Product Description
    • 8.12.5 Ortho Clinical Diagnostics Recent Development
  • 8.13 Qiagen
    • 8.13.1 Qiagen Corporation Information
    • 8.13.2 Qiagen Overview and Its Total Revenue
    • 8.13.3 Qiagen Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.13.4 Qiagen Product Description
    • 8.13.5 Qiagen Recent Development
  • 8.14 Codexis
    • 8.14.1 Codexis Corporation Information
    • 8.14.2 Codexis Overview and Its Total Revenue
    • 8.14.3 Codexis Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.14.4 Codexis Product Description
    • 8.14.5 Codexis Recent Development
  • 8.15 Bio-Rad Laboratories
    • 8.15.1 Bio-Rad Laboratories Corporation Information
    • 8.15.2 Bio-Rad Laboratories Overview and Its Total Revenue
    • 8.15.3 Bio-Rad Laboratories Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.15.4 Bio-Rad Laboratories Product Description
    • 8.15.5 Bio-Rad Laboratories Recent Development
  • 8.16 Oxford Nanopore
    • 8.16.1 Oxford Nanopore Corporation Information
    • 8.16.2 Oxford Nanopore Overview and Its Total Revenue
    • 8.16.3 Oxford Nanopore Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
    • 8.16.4 Oxford Nanopore Product Description
    • 8.16.5 Oxford Nanopore Recent Development

9 Production Forecasts by Regions

  • 9.1 Global Top Infectious Disease Testing Using PCR for IVD Regions Forecast by Revenue (2021-2026)
  • 9.2 Global Top Infectious Disease Testing Using PCR for IVD Regions Forecast by Production (2021-2026)
  • 9.3 Key Infectious Disease Testing Using PCR for IVD Production Regions Forecast
    • 9.3.1 North America
    • 9.3.2 Europe
    • 9.3.3 China
    • 9.3.4 Japan

10 Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region

  • 10.1 Global Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
  • 10.2 North America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
  • 10.3 Europe Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
  • 10.4 Asia Pacific Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
  • 10.5 Latin America Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)
  • 10.6 Middle East and Africa Infectious Disease Testing Using PCR for IVD Consumption Forecast by Region (2021-2026)

11 Value Chain and Sales Channels Analysis

  • 11.1 Value Chain Analysis
  • 11.2 Sales Channels Analysis
    • 11.2.1 Infectious Disease Testing Using PCR for IVD Sales Channels
    • 11.2.2 Infectious Disease Testing Using PCR for IVD Distributors
  • 11.3 Infectious Disease Testing Using PCR for IVD Customers

12 Market Opportunities & Challenges, Risks and Influences Factors Analysis

  • 12.1 Market Opportunities and Drivers
  • 12.2 Market Challenges
  • 12.3 Market Risks/Restraints
  • 12.4 Porter's Five Forces Analysis

13 Key Finding in The Global Infectious Disease Testing Using PCR for IVD Study

    14 Appendix

    • 14.1 Research Methodology
      • 14.1.1 Methodology/Research Approach
      • 14.1.2 Data Source
    • 14.2 Author Details

    Summary:
    Get latest Market Research Reports on COVID-19 Impact on Global Infectious Disease Testing Using PCR for IVD. Industry analysis & Market Report on COVID-19 Impact on Global Infectious Disease Testing Using PCR for IVD is a syndicated market report, published as COVID-19 Impact on Global Infectious Disease Testing Using PCR for IVD Market Insights, Forecast to 2026. It is complete Research Study and Industry Analysis of COVID-19 Impact on Global Infectious Disease Testing Using PCR for IVD market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $4,900.00
    $7,350.00
    $9,800.00
    3,900.40
    5,850.60
    7,800.80
    4,552.10
    6,828.15
    9,104.20
    754,306.00
    1,131,459.00
    1,508,612.00
    409,199.00
    613,798.50
    818,398.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report